SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
InterMune (nasdaq)ITMN
An SI Board Since March 2000
Posts SubjectMarks Bans Symbol
508 36 0 ITMN
Emcee:  Secret_Agent_Man Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
208quid, I think they'll test perfenidone in combo with actimmune. My guess isrkrw-4/8/2002
207Seems as though the Rochester Mayo Clinic hasn't found anything it likes in quidditch-4/8/2002
206>>Am J Respir Crit Care Med 1999 Apr;159(4 Pt 1):1061-9 Treatment of idituck-4/8/2002
205>>BRISBANE, Calif., April 8 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nastuck-4/8/2002
204Sorry, Quid. I apparently snipped the part about the firm she represented: Leerituck-4/5/2002
203Tuck, is she MS? Would this be initiation of coverage coming after the secondarquidditch-4/5/2002
202>>BOSTON, April 5 /PRNewswire/ -- This morning, Jennifer M. Chao, Senior Btuck-4/5/2002
201Wednesday March 27, 7:35 pm Eastern Time Press Release SOURCE: InterMune, Inc. IIRWIN JAMES FRANKEL-3/28/2002
200Trading today was interesting. It started out light. Then the stock started riIRWIN JAMES FRANKEL-3/28/2002
199<<<90% of the sales will disappear instantly if the Phase III data relerkrw-3/25/2002
198Hi Mike, "Maybe the theory is that sales are trending down now because DRsIRWIN JAMES FRANKEL-3/25/2002
197ThanksElmer-3/25/2002
19634, 33 and now watching. The drop seems to be driven by shorts. The price toIRWIN JAMES FRANKEL-3/25/2002
195I just don't understand all the attention paid to near-term actimmune sales.Michael Young-3/25/2002
194IF, What price would you buy ITMN? Regards, DElmer-3/25/2002
193>>LOS ANGELES, March 25 (Reuters) - Shares of biotechnology company Intermtuck-3/25/2002
192Joebt, Thanks for the post. It is appreciated. ijIRWIN JAMES FRANKEL-3/13/2002
191In all fairness, I would expect these types of articles under the circumstances.Michael Young-3/13/2002
190IJ--See my post to you on Yahoo-- should clarify the matter. messages.yahoo.com JOEBT1-3/13/2002
189I wrote this for RB in response to the Mayo study being commented on in the FortIRWIN JAMES FRANKEL-3/13/2002
188Here is an article that came out near the time the Mayo study was presented at CIRWIN JAMES FRANKEL-3/13/2002
187Fortune seems to be the latest tool of the shorts: Biotech's Next Big BlowuIRWIN JAMES FRANKEL-3/13/2002
186Thursday March 7, 7:39 pm Eastern Time Press Release SOURCE: InterMune, Inc. IRWIN JAMES FRANKEL-3/7/2002
185Seems to me that this doesn't mean a lot in the longer run. The stock is goMichael Young-3/6/2002
184Peter, You are certainly right about infergen, I stand corrected. I believe thsso-3/6/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News